Of note, the observation from the treatments of cisplatin/Pep#11/Pep#26 showing significantly greater tumor suppressive effects than cisplatin alone implicated a potential of conquering chemoresistance when MSI1/AGO2 interaction was disrupted. Here, AGO2 is linked to neoplasm.